Ariel Aviv

3.6k total citations · 1 hit paper
56 papers, 2.6k citations indexed

About

Ariel Aviv is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ariel Aviv has authored 56 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 16 papers in Pathology and Forensic Medicine and 15 papers in Oncology. Recurrent topics in Ariel Aviv's work include Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (15 papers) and Telomeres, Telomerase, and Senescence (11 papers). Ariel Aviv is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (15 papers) and Telomeres, Telomerase, and Senescence (11 papers). Ariel Aviv collaborates with scholars based in Israel, United States and Canada. Ariel Aviv's co-authors include Jonathan P. Gardner, Minoru Kimura, Masayuki Kimura, Bruce M. Psaty, Annette L. Fitzpatrick, Jeremy Walston, Russell P. Tracy, Richard A. Kronmal, Paula Herer and Rafael Luboshitzky and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ariel Aviv

53 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study

2006 630 citations Jonathan P. Gardner, Masayuki Kimura et al. American Journal of Epidemiology profile →

Peers

Countries citing papers authored by Ariel Aviv

Since Specialization

Citations

This map shows the geographic impact of Ariel Aviv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Aviv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Aviv more than expected).

Fields of papers citing papers by Ariel Aviv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Aviv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Aviv. The network helps show where Ariel Aviv may publish in the future.

Co-authorship network of co-authors of Ariel Aviv

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Aviv. A scholar is included among the top collaborators of Ariel Aviv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Aviv. Ariel Aviv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients and healthcare professionals’ perspectives on the implementation of shared decision making in multiple myeloma: a multinational qualitative study 2025 ·BMC Medical Informatics and Decision Making ·(unknown), (unknown), (unknown), (unknown), Kate Morgan, (unknown), Ariel Aviv, Varda Shoham, (unknown), Michel Delforge, (unknown), Rosanne Janssens, Isabelle Huys	0
2	Increased Risk of Non-Hodgkin Lymphoma in Autoimmune Hepatitis: A Large Retrospective Cohort Study 2024 ·Journal of Clinical Medicine ·(unknown), Ziv Neeman, Ariel Aviv, Rawi Hazzan	0
3	Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B‐Cell Lymphoma 2024 ·Hematological Oncology ·Meirav Kedmi, (unknown), Ohad Benjamini, Ginette Schiby, Iris Barshack, Stephen Raskin, Yael Eshet, Ramit Mehr, Netanel A. Horowitz, Ronit Gurion, Neta Goldschmidt, Chava Perry, Itai Levi, Ariel Aviv, Katrin Herzog‐Tzarfati, Arnon Nagler, Abraham Avigdor	0
4	Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study 2023 ·Annals of Hematology ·(unknown), Tzippy Shochat, Shlomzion Aumann, Boaz Nachmias, Neta Goldschmidt, (unknown), (unknown), Ariel Aviv, (unknown), Uri Abadi, Shai Shimony, Pia Raanani, Anat Gafter‐Gvili, Ronit Gurion	2
5	Early integration of palliative care for patients with haematological malignancies 2022 ·British Journal of Haematology ·Adir Shaulov, Ariel Aviv, (unknown), Camilla Zimmermann	24
6	Association of proton pump inhibitor use with the development of febrile neutropenia in lymphoma patients 2021 ·Expert Review of Hematology ·Rawi Hazzan, (unknown), Ziv Neeman, Ariel Aviv	3
7	The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia 2021 ·Frontiers in Immunology ·(unknown), Regina Michelis, (unknown), Judith Chezar, Tamar Tadmor, Ariel Aviv, Lev Shvidel, (unknown), Mona Shehadeh, (unknown), Ety Shaoul, Andrei Braester	9
8	Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway 2020 ·PLoS ONE ·Regina Michelis, Tamar Tadmor, Ariel Aviv, (unknown), (unknown), Lev Shvidel, Mona Shehadeh, (unknown), Andrei Braester	2
9	Attitudes toward death and death acceptance among hemato-oncologists: An Israeli sample 2020 ·Palliative & Supportive Care ·(unknown), (unknown), Ariel Aviv, Adir Shaulov, Michal Braun	6
10	A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity 2019 ·PLoS ONE ·Regina Michelis, Tamar Tadmor, (unknown), Mona Shehadeh, Lev Shvidel, Ariel Aviv, (unknown), Najib Dally, Naomi Rahimi‐Levene, (unknown), Andrei Braester	7
11	Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials 2018 ·European Journal Of Haematology ·Erel Joffe, Neta Goldschmidt, Osnat Bairey, Riva Fineman, Rosa Ruchlemer, Naomi Rahimi‐Levene, Lev Shvidel, Uri Greenbaum, Ariel Aviv, Tamar Tadmor, (unknown), Ariela Arad, Aaron Polliack, Yair Herishanu, (unknown)	5
12	Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival 2017 ·Hematological Oncology ·Erel Joffe, (unknown), Osnat Bairey, Riva Fineman, Rosa Ruchlemer, Naomi Rahimi‐Levene, Lev Shvidel, Uri Greenbaum, Ariel Aviv, Tamar Tadmor, Andrei Braester, Neta Goldschmidt, Aaron Polliack, Yair Herishanu	3
13	Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study 2015 ·Leukemia & lymphoma ·Anat Gafter‐Gvili, Elena Ribakovsky, (unknown), Abraham Avigdor, Ariel Aviv, Liat Vidal, Ron Ram, Chava Perry, Irit Avivi, Meirav Kedmi, Arnon Nagler, Pia Raanani, Ronit Gurion	23
14	Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis 2013 ·Cancer ·Tamar Tadmor, Lev Shvidel, Ariel Aviv, Rosa Ruchlemer, Osnat Bairey, (unknown), Yair Herishanu, (unknown), (unknown), (unknown), Jonathan Ben‐Ezra, Jacob Bejar, Aaron Polliack, (unknown)	11
15	Leukocyte Telomere Length Is Associated With Noninvasively Measured Age-Related Disease: The Cardiovascular Health Study 2011 ·The Journals of Gerontology Series A ·Jason L. Sanders, Annette L. Fitzpatrick, Robert M. Boudreau, Alice M. Arnold, Ariel Aviv, Minoru Kimura, Linda F. Fried, T. B. Harris, Anne B. Newman	66
16	Telomere Dynamics in Rhesus Monkeys: No Apparent Effect of Caloric Restriction 2011 ·The Journals of Gerontology Series A ·Daniel L. Smith, Julie A. Mattison, R A Desmond, Jonathan P. Gardner, Masayuki Kimura, G. S. Roth, Donald K. Ingram, David B. Allison, Ariel Aviv	32
17	A genome-wide association study identifies a novel locus on chromosome 18q12.2 influencing white cell telomere length 2009 ·Journal of Medical Genetics ·Massimo Mangino, J. Brent Richards, Nicole Soranzo, Guanghua Zhai, Ariel Aviv, Ana M. Valdes, Nilesh J. Samani, Panos Deloukas, Tim D. Spector	53
18	Telomere Length and Mortality: A Study of Leukocytes in Elderly Danish Twins 2008 ·American Journal of Epidemiology ·Minoru Kimura, Jacob Hjelmborg, Jonathan P. Gardner, Lise Bathum, Michael Brimacombe, Xiaoxiao Lu, Lene Christiansen, James W. Vaupel, Ariel Aviv, Kaare Christensen	210
19	Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study 2006 ·Annals of the Rheumatic Diseases ·Guangju Zhai, Ariel Aviv, David J. Hunter, David J. Hart, Jonathan P. Gardner, Masayuki Kimura, Xiaoyong Lu, Ana M. Valdes, Tim D. Spector	60
20	Cytosolic Ca2+ attenuates ANF-induced cyclic GMP response in vascular smooth muscle cells 1989 ·Journal of Hypertension ·Makiko Nakamura, Nobuo Hatori, Atsushi Nakamura, Burton P. Fine, Ariel Aviv	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact